This is one of many milestones our company has achieved since the launch of VerteLoc™ in late May
Winston Salem, NC (PRWEB) December 3, 2008
Winston-Salem, NC (PRWEB) December 3, 2008 -- VG Innovations, Inc. (VGI), announced today that over 100 patients have received implantation of the VerteLoc™ Minimally Invasive Spine Stabilization System.
"This is one of many milestones our company has achieved since the launch of VerteLoc™ in late May," stated VGI's President and CEO, Dan Grayson. "We have received very positive feedback from our surgeon users, who have conveyed that our dual geometric-shaped implant provides a clear advantage when dealing with the biomechanical characteristics of the spinal column. Our review of several computed tomography images from random patients, at 12 weeks post-operative, has exhibited successful spinal facet fusion with no implant migration."
VGI was just recognized by Millennium Research Group in its report, US Markets for Minimally Invasive Spine Technologies 2008, as being the top emerging company in the facet fixation market space, which the report estimates to be worth $385 million by 2012. The report stated, "This company (VGI) will be able to leverage off of efforts made by its predecessors in promoting facet fixation technology using an allograft. Furthermore, its patent pending rectangular design, with dual vertical stabilizers, is expected to minimize the risk of dowel displacement following implantation, a major concern with competing allograft dowels."
"To be recognized by the leading source in medical device market analysis at such an early stage is quite an accomplishment," Grayson added. "However, I think the report and what it stated regarding VGI and the VerteLoc™ system is right on target. The system offers a significant advancement in design to improve the quality of life for those who suffer with debilitating back pain."
The VerteLoc™ Minimally Invasive Spine Stabilization System is designed to allow earlier intervention in the continuum of spinal care. The procedure should prolong or prevent more invasive spine procedures in indicated patients, which would provide significant benefits to the quality of life versus traditional methods of spinal fusion.
VG Innovations, Inc, is a privately held company and was formed in late 2007. The company is in the business of developing and commercializing proprietary, implantable devices with a specific focus on minimally invasive surgical products that could provide better surgical solutions over present technology. The products are designed to treat specific spinal disease indications that affect millions of people. More information on the company and its products can be found at: http://www.verteloc.com